Development and preliminary analytical characterisation of an in-house indirect ELISA for relative measurement of IgG binding to SARS-CoV-2 spike RBD (Omicron BA.1)
Year: 2026
Type: article
Abstract: We developed an in-house indirect ELISA for relative measurement of IgG binding to the SARS-CoV-2 Spike receptor-binding domain (RBD; Omicron BA.1). Four antigen coating concentrations and three serum dilutions were evaluated using an internal convalescent-serum calibrator assigned arbitrary units (AU/mL). A coating concentration of 2 µg/mL and a serum dilution of 1:100 were selected. The calibration means showed a linear relationship (R² > 0.9999), although serum dilution responses did not demonstrate parallelism with the calibrator. Within-run OD-based coefficients of variation were 4.1–6.5%, and between-run AU-based coefficients of variation were 2.4–8.8% across three days with one operator. Background-derived analytical limits and an operational limit of quantification were characterised as preliminary estimates. In a pilot panel of 10 sera from patients with RT-PCR-confirmed infection and 10 pre-pandemic sera, the cut-off (0.134 OD₄₀₅; mean + 3 SD of the pre-pandemic sera) gave a sensitivity of 90.0% (95% CI 59.6–98.2%). The same negative sera were used to set the cut-off, thus the specificity was estimated by leave-one-out analysis and was 90.0% (59.6–98.2%), with an accuracy of 90.0% (69.9–97.2%). Apparent specificity at the fixed cut-off was 100%. The ROC AUC was 0.99 (95% CI 0.94–1.00). These findings support further development of a research serology platform, with independent clinical validation and calibration harmonisation needed before broader quantitative or diagnostic use.
Source: Scientific Reports
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7212167072
